The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.64
Bid: 10.66
Ask: 11.18
Change: 0.34 (3.30%)
Spread: 0.52 (4.878%)
Open: 10.64
High: 10.64
Low: 10.64
Prev. Close: 10.30
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual General Meeting 2016 Call

3 Feb 2016 09:28

RNS Number : 9335N
Banco Bilbao Vizcaya Argentaria SA
03 February 2016
 

 

 

 

TO THE CNMV (SECURITIES EXCHANGE COMMISSION)

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), in compliance with the Securities Exchange legislation, hereby files the following

 

 

RELEVANT EVENT

 

 

BBVA´s Board of Directors, at the meeting held on 2nd February 2016, has resolved to call the Annual General Meeting of Shareholders to be held in Bilbao, at Palacio Euskalduna, calle Abandoibarra number 4 on 10th March 2016, at 12:00 at first summons, and in the same place and at the same time on 11th March 2016 at second summons. It will have the agenda attached.

 

More information as regards Annual General Meeting is included in the press release attached.

 

 

Madrid, 3rd February 2016

 

 

 

 

 

 

 

 

 

2016 ANNUAL GENERAL MEETING OF SHAREHOLDERS

 

AGENDA

 

 

ONE. Financial statements, profit allocation and corporate management:

1.1 Examination and approval of the financial statements and management reports of BBVA and its consolidated group corresponding to the year ending on December 31, 2015.

1.2 Approval of the allocation of the 2015 profit.

 

1.3 Approval of corporate management during 2015.

 

TWO. Adoption of the following resolutions regarding the re-election, ratification and appointment of members to the Board of Directors:

 

2.1 Re-election of Mr. Francisco González Rodríguez.

 

2.2 Ratification and appointment of Mr. Carlos Torres Vila.

 

2.3 Appointment of Mr. James Andrew Stott.

 

2.4 Appointment of Mr. Sunir Kumar Kapoor.

 

Pursuant to paragraph 2 of article 34 of the Company Bylaws, determination of the number of directors at the number resulting from the resolutions adopted under this item on the agenda, which will be reported to the Annual General Meeting for all due purposes.

 

THREE. Approval of four capital increases to be charged against voluntary reserves for the purpose of implementing the shareholder remuneration system called "Dividend Option":

 

3.1 Increase in share capital, according to the terms of the resolution, by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently outstanding, against voluntary reserves. Commitment to purchase shareholder's free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. To confer authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this Annual General Meeting, to take the measures necessary for its execution and to adapt the wording of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and international bodies for admitting the new shares to trading on the Spanish and international securities exchanges on which BBVA shares are traded, in the required manner for each one.

 

3.2 Increase in share capital, according to the terms of the resolution, by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently outstanding, against voluntary reserves. Commitment to purchase shareholder's free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. To confer authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this Annual General Meeting, to take the measures necessary for its execution and to adapt the wording of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and international bodies for admitting the new shares to trading on the Spanish and international securities exchanges on which BBVA shares are traded, in the required manner for each one.

 

3.3 Increase in share capital, according to the terms of the resolution, by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently outstanding, against voluntary reserves. Commitment to purchase shareholder's free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. To confer authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this Annual General Meeting, to take the measures necessary for its execution and to adapt the wording of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and international bodies for admitting the new shares to trading on the Spanish and international securities exchanges on which BBVA shares are traded, in the required manner for each one.

 

3.4 Increase in share capital, according to the terms of the resolution, by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently outstanding, against voluntary reserves. Commitment to purchase shareholder's free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. To confer authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this Annual General Meeting, to take the measures necessary for its execution and to adapt the wording of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and international bodies for admitting the new shares to trading on the Spanish and international securities exchanges on which BBVA shares are traded, in the required manner for each one.

 

 

FOUR. Extension of the remuneration System with deferred distribution of BBVA shares for non-executive directors of BBVA that was approved by the Annual General Meeting held on March 18, 2006 and extended through an agreement by the Annual General Meeting held on March 11, 2011.

 

FIVE. Re-election of the auditors of BBVA and its consolidated group for 2016.

 

SIX. Conferral of authority on the Board of Directors, which may in turn delegate such authority, to formalize, correct, interpret and implement the resolutions adopted by the General Meeting.

 

SEVEN. Consultative vote on the Annual Report on BBVA Directors' Remuneration.

 

 

BBVA internationalizes its Board of Directors

 

 

 

 

BBVA will propose the appointment of Sunir Kapoor and Andrew Stott as new independent board members during its Annual Shareholders' Meeting. The Meeting will be held in Bilbao on March 11th, 2016, as notified in the Relevant Event containing the agenda and to which this press release is appended.

 

The BBVA's Board of Directors has decided to propose the appointment of Sunir Kapoor and Andrew Stott as new independent board members. They are to replace Ramón Bustamante y de la Mora and Ignacio Ferrero Jordi, upon conclusion of their three-year appointment as directors. First appointed in year 2000, Mr. Bustamante and Mr. Ferrero had no longer the status of independent board members, as they had held their post for more than 12 years, in accordance with the Spanish Corporate Enterprises Act.

 

BBVA maintains its policy of having at least 50% of independent members in its Board of Directors. With these appointments, the Board would continue to be integrated by a majority of independent members: 8 out of a total of 15, with just three executive members.

 

With these proposals BBVA seeks to promote the diversity of its Board, proposing the accession of two members with solid international exposure to strengthen the experience in this field in the Board of Directors, while bringing in profiles with expertise in fields that are deemed of maximum relevance for the Group.

 

Sunir Kapoor has an extensive background in the field of information technologies, digital business and cyber security. He has held senior positions in some of the world's top technology companies, including Microsoft Corporation, as head of its European businesses and Director of Worldwide Business Strategy; and Oracle Corporation, as Vice President Strategy, Marketing & Planning. Between 2005 and 2011, Mr. Kapoor was President & CEO of UBmatrix, one of the original inventors of the XBRL standard. Since 2012, he has been developing his activity as an independent consultant and advisor to boards of directors at different leading technology companies such as Panda Security, GlobalLogic, Merrill Corporation or Avni Networks.

 

Andrew Stott has held several senior positions at Oliver Wyman, before becoming a partner in the firm and member of its Board of Directors at a global level. He has also served as member of the Board of Directors of Barclays Spain and chair of its Audit and Risk commission, member of the Board of Catenon, with independent status, and since 2009, as founder of Hermes Partners.

 

 

Other proposals

 

Other issues will be submitted for approval during the Meeting, including the endorsement of BBVA's annual statements for 2015, the capital increases required to cover eventual dividend payments on shares during the year, and the renewal of Deloitte's appointment as account auditor of the Bank and the Group for year 2016. BBVA will also propose to its board the reappointment of both Francisco González and Carlos Torres Vila as board members. Also, the English translation of the "Presidente" and "Consejero Delegado" positions has been changed to "Group Executive Chairman" and "CEO", respectively, in compliance with current practices in other institutions across the sector.

 

Finally, during the Meeting the Company will share its insights into the progress made by BBVA in its corporate governance system throughout 2015, including the expansion of the functions that correspond to the coordinator-director, and the increase in competencies of the Board and of its control commissions. 

 

Contact details:

BBVA Corporate Communications

Tel. +34 91 537 67 51

comunicacion.corporativa@bbva.com

 

For more financial information about BBVA visit:

http://shareholdersandinvestors.bbva.com

 

For more BBVA news visit: info.bbva.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMAKNDBCBKKPBK
Date   Source Headline
14th Dec 20205:21 pmRNSAgreement with Allianz
27th Nov 20207:00 amRNSEnd of conversations with Banco de Sabadell
16th Nov 20205:13 pmRNSConversations with Banco de Sabadell, S.A.
16th Nov 20207:00 amRNSPresentation_Sale of BBVA's U.S. subsidiary to PNC
16th Nov 20207:00 amRNSSale of BBVA's U.S. subsidiary to PNC
30th Oct 20207:21 amRNS3Q20 Results Presentation
30th Oct 20207:09 amRNS3Q20 Quarterly Report
30th Oct 20207:05 amRNS3Q20 Results Press Release
21st Oct 20205:06 pmRNS3Q20 Results Presentation Announcement
23rd Sep 20207:48 amRNSBBVA CEO Presentation
14th Aug 20209:00 amRNSPost-Stab Notice BBVA GBP 300m
30th Jul 20207:00 amRNS2Q20 Results Presentation
30th Jul 20207:00 amRNS2Q20 Results Report
30th Jul 20207:00 amRNS2Q20 Results Press Release
21st Jul 20204:57 pmRNS2Q20 Results Presentation Announcement
14th Jul 202012:12 pmRNSPre-Stab Notice BBVA GBP 300m due 15th July
7th Jul 20205:20 pmRNSOffer of securities convertible into shares_2
7th Jul 20208:23 amRNSOffer of securities convertible into shares
3rd Jul 202010:34 amRNSPost-stab Notice BBVA EUR 1bn
23rd Jun 20207:00 amRNSFitch Rating Update
27th May 20205:41 pmRNSPre-Stab Notice BBVA EUR 1BN due 4th June 2020
30th Apr 20207:28 amRNS1Q20 Results Press Release
30th Apr 20207:05 amRNSNew Composition BD Committees
30th Apr 20207:05 amRNS1Q20 Results Report
30th Apr 20207:00 amRNS1Q20 Results Presentation
30th Apr 20207:00 amRNSDividend Policy
28th Apr 20207:00 amRNSAgreement between BBVA and Allianz
21st Apr 20205:00 pmRNS1Q20 Results Presentation Announcement
9th Apr 20208:21 amRNSPotential Note Purchase
16th Mar 20207:00 amRNSPrudential Relevance Report (Pillar III) 2019
13th Mar 20203:12 pmRNSResolutions adopted by the AGM 2020
10th Mar 20205:30 pmRNSBBVA Statement to Shareholders 2020 AGM
12th Feb 20208:50 amRNS2020 AGM Proposed Resolutions
11th Feb 20207:00 amRNSFinal dividend calendar 2019
10th Feb 20205:33 pmRNS2020 AnnualGeneral Meeting Call
5th Feb 20204:26 pmRNSPost Stabilisation Notice - BBVA S.A.
31st Jan 20207:28 amRNS4Q19 Results Presentation
31st Jan 20207:25 amRNS4Q19 Results Press Release
31st Jan 20207:21 amRNS4Q19 Results Report
31st Jan 20207:14 amRNSFinal Dividend for 2019
21st Jan 20205:23 pmRNS4Q19 Results Presentation Announcement
7th Jan 20208:25 amRNSPre Stabilisation Notice - BBVA S.A
23rd Dec 20195:15 pmRNSEarly redemption of preferred securities
19th Dec 20195:48 pmRNSAdjustment Goodwill Group investment in the USA
5th Dec 201911:48 amRNSSREP Capital Requirements 2020
19th Nov 20196:30 pmRNSMREL Requirement
12th Nov 20198:50 amRNSPost-Stabilisation Notice - BBVA
31st Oct 20197:04 amRNS3Q19 Results Presentation
31st Oct 20197:00 amRNS3Q19 Results Report
31st Oct 20197:00 amRNS3Q19 Results Press Release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.